HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aurelia Vattai Selected Research

Neoplasms (Cancer)

7/2023Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRĪ±2 Determine Survival in Breast Cancer in Opposite Ways.
7/2023Prostaglandin E2 receptor EP1 expression in vulvar cancer.
1/2023RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro.
11/2021Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer.
7/2021Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.
3/2021EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer.
12/2020LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients.
12/2020Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.
9/2020Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).
7/2020Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aurelia Vattai Research Topics

Disease

14Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2024 - 07/2017
13Neoplasms (Cancer)
07/2023 - 10/2018
6Breast Neoplasms (Breast Cancer)
07/2023 - 09/2017
6Spontaneous Abortion (Miscarriage)
01/2021 - 01/2015
5Carcinogenesis
07/2023 - 01/2018
5Habitual Abortion (Recurrent Miscarriage)
01/2021 - 01/2015
4Vulvar Neoplasms (Vulvar Cancer)
08/2023 - 12/2020
4Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 01/2019
3Carcinoma (Carcinomatosis)
08/2023 - 12/2020
3Pre-Eclampsia (Preeclampsia)
01/2022 - 07/2017
2Uterine Cervical Dysplasia
08/2023 - 07/2020
2Inflammation (Inflammations)
07/2023 - 03/2021
2Ovarian Epithelial Carcinoma
08/2021 - 10/2020
2Gestational Diabetes (Gestational Diabetes Mellitus)
11/2017 - 07/2017
2Fetal Growth Retardation (Intrauterine Growth Retardation)
11/2017 - 07/2017
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024
1Maternal Obesity
01/2023
1HELLP Syndrome
01/2022
1Neoplasm Metastasis (Metastasis)
09/2020
1Hydatidiform Mole (Molar Pregnancy)
01/2020
1Adenocarcinoma
12/2019
1Colonic Neoplasms (Colon Cancer)
12/2017
1Premature Birth (Birth, Premature)
11/2017
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
07/2017
1Endometriosis
07/2017
1Thrombophilia
07/2017
1Infertility (Sterility)
07/2017

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2015
5Biomarkers (Surrogate Marker)IBA
01/2024 - 12/2020
5Thyroid HormonesIBA
08/2021 - 01/2015
4ParaffinIBA
08/2023 - 09/2017
3Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
07/2023 - 01/2015
3Prostaglandin Receptors (Prostaglandin Receptor)IBA
03/2021 - 07/2017
3Formaldehyde (Formol)FDA Link
07/2020 - 09/2017
2Chemokine CCL22IBA
08/2023 - 12/2019
2Protein Isoforms (Isoforms)IBA
07/2023 - 01/2015
2Dinoprostone (PGE2)FDA Link
07/2023 - 09/2020
2Co-Repressor ProteinsIBA
11/2021 - 07/2020
2Trace amine-associated receptor 1IBA
08/2021 - 09/2017
2RNA (Ribonucleic Acid)IBA
07/2021 - 12/2020
2Bromodeoxyuridine (BrdU)IBA
03/2021 - 12/2020
2Messenger RNA (mRNA)IBA
01/2021 - 01/2015
2Plasminogen Activator Inhibitor 1IBA
09/2020 - 07/2017
2GTP-Binding Proteins (G-Protein)IBA
09/2020 - 01/2018
2AntibodiesIBA
01/2020 - 01/2019
2Estrogen ReceptorsIBA
01/2019 - 01/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2024
1Pemetrexed (MTA)FDA Link
08/2023
1progesterone receptor AIBA
02/2023
1Interleukin-6 (Interleukin 6)IBA
01/2023
1CeramidesIBA
01/2023
1ElementsIBA
11/2021
1EnzymesIBA
11/2021
13-iodothyronamineIBA
08/2021
1B7-H1 AntigenIBA
07/2021
1L-161982IBA
03/2021
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2021
1Hormones (Hormone)IBA
01/2021
1SteroidsIBA
01/2021
1Retinoid X Receptors (Retinoid X Receptor)IBA
01/2021
1GlycodelinIBA
01/2021
1Epinephrine (Adrenaline)FDA LinkGeneric
12/2020
1Carboxy-LyasesIBA
12/2020
1Levodopa (L Dopa)FDA LinkGeneric
12/2020
1CatecholaminesIBA
12/2020
1indoleIBA
12/2020
1PlatinumIBA
10/2020
1CateninsIBA
10/2020
1Urokinase Plasminogen Activator ReceptorsIBA
09/2020
1sulprostoneIBA
09/2020
1LigandsIBA
07/2020
1Nuclear Receptor Co-Repressor 1IBA
07/2020
1Peptide Elongation Factors (Elongation Factor)IBA
01/2020
1Galectin 3 (LGALS3)IBA
01/2020
1Indicators and Reagents (Reagents)IBA
12/2019
1EpitopesIBA
01/2019
1Mucin-1 (CA 15-3 Antigen)IBA
01/2019
1Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2019
1thyronamineIBA
01/2019
1tetraiodothyroacetic acid (TA(4))IBA
01/2019
1AntigensIBA
10/2018
1Oncogene Proteins (Oncogene Protein)IBA
10/2018
1Dopamine Receptors (Dopamine Receptor)IBA
05/2018
1Dopamine (Intropin)FDA LinkGeneric
05/2018
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2018
1Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
02/2018
1Estrogens (Estrogen)FDA Link
01/2018
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2018
1Raloxifene Hydrochloride (Evista)FDA Link
01/2018
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2018
1Estrogen Receptor alphaIBA
01/2018
1Histones (Histone)IBA
12/2017
1Calcitriol Receptors (Calcitriol Receptor)IBA
11/2017
1Plasminogen InactivatorsIBA
07/2017
1ProstaglandinsIBA
07/2017
1Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
07/2017

Therapy/Procedure

9Therapeutics
08/2023 - 09/2017
2Immunotherapy
07/2021 - 12/2019